| 1 | English French Notes Complete/Exclude
|
|---|
| 2 | ABDOMINAL INFECTION..............: NA, no treatment
|
|---|
| 3 | ABSCESS..........................: NA, no treatment
|
|---|
| 4 | ADMISSION FOR NEUTROPENIA........: NA, no treatment
|
|---|
| 5 | ANASTOMOTIC DEHISCENCE...........: NA, no treatment
|
|---|
| 6 | BLEEDING/HEMATOMA................: NA, no treatment
|
|---|
| 7 | DEHYDRATION......................: NA, no treatment
|
|---|
| 8 | DIARRHEA.........................: NA, no treatment
|
|---|
| 9 | EARLY BOWEL OBSTRUCTION..........: NA, no treatment
|
|---|
| 10 | PERINEAL INFECTION...............: NA, no treatment
|
|---|
| 11 | PNEUMONIA........................: NA, no treatment
|
|---|
| 12 | PROCTITIS........................: NA, no treatment
|
|---|
| 13 | PULMONARY EMBOLISM...............: NA, no treatment
|
|---|
| 14 | RADIATION ENTERITIS..............: NA, no treatment
|
|---|
| 15 | STOMA COMPLICATION...............: NA, no treatment
|
|---|
| 16 | URINARY TRACT INFECTION..........: NA, no treatment
|
|---|
| 17 | POSTOPERATIVE DEATH W/I 30 DAYS: NA, no surgery
|
|---|
| 18 | 763 ADDITIONAL SURGICAL PROCEDURES..
|
|---|
| 19 | 764 LAPAROSCOPY USED DURING SURGERY.
|
|---|
| 20 | 765 METHOD OF ANASTOMOSIS...........
|
|---|
| 21 | 766 DIST OF ANASTOMOSIS FROM DENTATE
|
|---|
| 22 | 59 RESIDUAL PRIMARY TUMOR..........
|
|---|
| 23 | 769 PATHOLOGICAL STATUS...........
|
|---|
| 24 | 770 ABDOMINAL INFECTION...........
|
|---|
| 25 | 772 ADMISSION FOR NEUTROPENIA.....
|
|---|
| 26 | 773 ANASTOMOTIC DEHISCENCE........
|
|---|
| 27 | 776 EARLY BOWEL OBSTRUCTION.......
|
|---|
| 28 | 777 PERINEAL INFECTION............
|
|---|
| 29 | 780 PULMONARY EMBOLISM............
|
|---|
| 30 | 781 RADIATION ENTERITIS...........
|
|---|
| 31 | 782 STOMA COMPLICATION............
|
|---|
| 32 | 783 URINARY TRACT INFECTION.......
|
|---|
| 33 | 441 POSTOPERATIVE DEATH W/I 30 DAYS.
|
|---|
| 34 | DATE RADIATION STARTED..........:
|
|---|
| 35 | DATE RADIATION THERAPY ENDED....: 00/00/0000
|
|---|
| 36 | ENDOCAVITARY RADIATION..........: None
|
|---|
| 37 | INTRA-OPERATIVE RAD THERAPY.....: No
|
|---|
| 38 | PRIMARY TUMOR RAD DOSE W BOOST..: No radiation therapy
|
|---|
| 39 | NUMBER OF RADIATION TREATMENTS..: None
|
|---|
| 40 | DATE RADIATION THERAPY ENDED....: 99/99/9999
|
|---|
| 41 | ENDOCAVITARY RADIATION..........: Unknown
|
|---|
| 42 | INTRA-OPERATIVE RAD THERAPY.....: Unknown
|
|---|
| 43 | PRIMARY TUMOR RAD DOSE W BOOST..: Unknown if received radiation therapy
|
|---|
| 44 | NUMBER OF RADIATION TREATMENTS..: Unknown if radiation given
|
|---|
| 45 | 361 DATE RADIATION THERAPY ENDED....
|
|---|
| 46 | 784 ENDOCAVITARY RADIATION..........
|
|---|
| 47 | 785 INTRA-OPERATIVE RAD THERAPY.....
|
|---|
| 48 | 786 PRIMARY TUMOR RAD DOSE W BOOST..
|
|---|
| 49 | 787 NUMBER OF RADIATION TREATMENTS..
|
|---|
| 50 | DATE CHEMOTHERAPY STARTED.......:
|
|---|
| 51 | ADJUVANT CHEMO W BEAM RADIATION.: No concomitant treatment
|
|---|
| 52 | ADJUVANT THERAPY:
|
|---|
| 53 | DURATION OF ADJUVANT THERAPY....: No adjuvant therapy
|
|---|
| 54 | COMPLETED DURATION OF THERAPY...: No (0-1 cycle)
|
|---|
| 55 | ADJUVANT CHEMO W BEAM RADIATION.: Unknown if therapy concomitant
|
|---|
| 56 | DURATION OF ADJUVANT THERAPY....: Unknown if therapy given
|
|---|
| 57 | COMPLETED DURATION OF THERAPY...: Unknown if therapy given
|
|---|
| 58 | 788 ADJUVANT CHEMO W BEAM RADIATION.
|
|---|
| 59 | 794 DURATION OF ADJUVANT THERAPY....
|
|---|
| 60 | 795 COMPLETED DURATION OF THERAPY...
|
|---|
| 61 | WERE OTHER REFERRALS MADE
|
|---|
| 62 | TABLE V - QUALITY OF LIFE
|
|---|
| 63 | WERE OTHER REFERRALS MADE:
|
|---|
| 64 | 796 NUTRITIONAL CONSULTATION
|
|---|
| 65 | 797 OCCUPATIONAL THERAPY....
|
|---|
| 66 | 563 PHYSICAL THERAPY........
|
|---|
| 67 | 798 OSTOMY CONSULTATION.....
|
|---|
| 68 | 70DATE OF FIRST RECURRENCE......
|
|---|
| 69 | 71TYPE OF FIRST RECURRENCE......
|
|---|
| 70 | DATE OF LAST CONTACT OR DEATH:
|
|---|
| 71 | 15VITAL STATUS.................
|
|---|
| 72 | CANCER STATUS................:
|
|---|
| 73 | 81COMPLETED BY.................
|
|---|
| 74 | 82REVIEWED BY CANCER COMMITTEE.
|
|---|
| 75 | 10. FAMILY HISTORY OF COLORECTAL CA..:
|
|---|
| 76 | 11. PERSONAL HISTORY OF COLORECTAL CA:
|
|---|
| 77 | 12. MULTI 1997 COLON/RECTUM PRIMARIES:
|
|---|
| 78 | 13. PERSONAL HISTORY OF NON-COLORECTAL CANCER:
|
|---|
| 79 | PROSTATE.........:
|
|---|
| 80 | STOMACH..........:
|
|---|
| 81 | THYROID..........:
|
|---|
| 82 | UTERUS...........:
|
|---|
| 83 | OVARIAN CARCINOMA:
|
|---|
| 84 | OTHER............:
|
|---|
| 85 | 14. PREVIOUS TAH/BSO.................:
|
|---|
| 86 | 15. OTHER PRIOR CONDITIONS:
|
|---|
| 87 | PRIOR POLYPS.....:
|
|---|
| 88 | POLYPS...........:
|
|---|
| 89 | 17. DURATION OF SIGNS/SYMPTOMS PRESENT AT INITIAL DIAGNOSIS (months):
|
|---|
| 90 | BOWEL OBSTRUCTION..............:
|
|---|
| 91 | CHANGE IN BOWEL HABIT..........:
|
|---|
| 92 | EMER PRESENTATION-OBSTRUCTION..:
|
|---|
| 93 | OCCULT BLOOD ONLY IN STOOL.....:
|
|---|
| 94 | RECTAL BLEEDING (MELENA).......:
|
|---|
| 95 | 18. INITIAL METHODS OF DIAGNOSIS:
|
|---|
| 96 | SCREENING DIGITAL RECTAL EXAM..:
|
|---|
| 97 | SCREENING PHYSICAL EXAM........:
|
|---|
| 98 | 19. REASON LEADING TO EVENTUAL DX....:
|
|---|
| 99 | 20. DIAGNOSTIC EVALUATION:
|
|---|
| 100 | BARIUM ENEMA, DOUBLE CONTRAST..:
|
|---|
| 101 | BARIUM ENEMA, SINGLE CONTRAST..:
|
|---|
| 102 | BARIUM ENEMA, NOS..............:
|
|---|
| 103 | BIOPSY OF PRIMARY SITE.........:
|
|---|
| 104 | BIOPSY OF METASTATIC SITE......:
|
|---|
| 105 | CT SCAN OF CHEST...............:
|
|---|
| 106 | CT SCAN OF LIVER...............:
|
|---|
| 107 | CT SCAN OF PRIMARY SITE........:
|
|---|
| 108 | CHEST ROENTGENOGRAM............:
|
|---|
| 109 | DIGITAL RECTAL EXAM............:
|
|---|
| 110 | FLEXIBLE SIGMOIDOSCOPY.........:
|
|---|
| 111 | INTRAVENOUS PYELOGRAM..........:
|
|---|
| 112 | SERUM-LIVER FUNCTION TEST......:
|
|---|
| 113 | STOOL GUAIAC (OCCULT BLOOD)....:
|
|---|
| 114 | 21. LEVEL OF TUMOR BY ENDOSCOPIC EXAM:
|
|---|
| 115 | 22. LEVEL OF RECTAL TUMOR............:
|
|---|
| 116 | 23. DATE OF INITIAL DIAGNOSIS........:
|
|---|
| 117 | 24. PRIMARY SITE.....................:
|
|---|
| 118 | 25. HISTOLOGY/26. BEHAVIOR CODE......:
|
|---|
| 119 | 28. DIAGNOSTIC CONFIRMATION..........:
|
|---|
| 120 | Print Colorectal Cancer PCE
|
|---|
| 121 | PCE Study of Colorectal Cancer
|
|---|
| 122 | 29. SIZE OF TUMOR (mm)...............:
|
|---|
| 123 | 30. REGIONAL NODES EXAMINED..........:
|
|---|
| 124 | 31. REGIONAL NODES POSITIVE..........:
|
|---|
| 125 | 32. AJCC CLINICAL STAGE (cTNM):
|
|---|
| 126 | AJCC STAGE.....................:
|
|---|
| 127 | 33. AJCC PATHOLOGIC STAGE (pTNM):
|
|---|
| 128 | 34. STAGED BY:
|
|---|
| 129 | CLINICAL STAGE.................:
|
|---|
| 130 | PATHOLOGIC STAGE...............:
|
|---|
| 131 | 35. MARGIN OF RESECTION:
|
|---|
| 132 | PROXIMAL MARGIN................:
|
|---|
| 133 | DISTAL MARGIN..................:
|
|---|
| 134 | RADIAL MARGIN..................:
|
|---|
| 135 | 36. DISTANCE TO MUCOSAL MARGIN.......:
|
|---|
| 136 | 37. DISTANCE TO RADIAL MARGIN........:
|
|---|
| 137 | 38. BLOOD VESSEL/LYMPHATIC INVASION..:
|
|---|
| 138 | 39. EXTRAMURAL VENOUS INVASION.......:
|
|---|
| 139 | 40. PROMINENT LYMPHOID INFILTRATE....:
|
|---|
| 140 | 41. PHYSICIAN PROVIDING TREATMENT....:
|
|---|
| 141 | 42. FIRST COURSE OF TREATMENT DATE...:
|
|---|
| 142 | 43. DATE OF INPATIENT ADMISSION......:
|
|---|
| 143 | 44. DATE OF INPATIENT DISCHARGE......:
|
|---|
| 144 | 45. NON CANCER-DIRECTED SURGERY DATE.:
|
|---|
| 145 | 46. NON CANCER-DIRECTED SURGERY......:
|
|---|
| 146 | 47. SURGERY OF PRIMARY SITE DATE.....:
|
|---|
| 147 | 48. SURGERY OF PRIMARY SITE..........:
|
|---|
| 148 | 49. ADDITIONAL SURGICAL PROCEDURES...:
|
|---|
| 149 | 50. LAPAROSCOPY USED DURING SURGERY..:
|
|---|
| 150 | 51. METHOD OF ANASTOMOSIS............:
|
|---|
| 151 | 52. DIST OF ANASTOMOSIS FROM DENTATE.:
|
|---|
| 152 | 53. RESIDUAL PRIMARY TUMOR...........:
|
|---|
| 153 | 54. OTHER SURGERY:
|
|---|
| 154 | PATHOLOGICAL STATUS............:
|
|---|
| 155 | 55. COMPLICATIONS AFTER FIRST COURSE OF TREATMENT:
|
|---|
| 156 | ABDOMINAL INFECTION......:
|
|---|
| 157 | PERINEAL INFECTION.......:
|
|---|
| 158 | PNEUMONIA................:
|
|---|
| 159 | ADMISSION FOR NEUTROPENIA:
|
|---|
| 160 | PROCTITIS................:
|
|---|
| 161 | ANASTOMOTIC DEHISCENCE...:
|
|---|
| 162 | PULMONARY EMBOLISM.......:
|
|---|
| 163 | RADIATION ENTERITIS......:
|
|---|
| 164 | STOMA COMPLICATION.......:
|
|---|
| 165 | URINARY TRACT INFECTION..:
|
|---|
| 166 | EARLY BOWEL OBSTRUCTION..:
|
|---|
| 167 | 56. POSTOPERATIVE DEATH W/I 30 DAYS:
|
|---|
| 168 | 57. DATE RADIATION STARTED...........:
|
|---|
| 169 | 58. DATE RADIATION THERAPY ENDED.....:
|
|---|
| 170 | 59. ENDOCAVITARY RADIATION...........:
|
|---|
| 171 | 60. INTRA-OPERATIVE RAD THERAPY......:
|
|---|
| 172 | 61. PRIMARY TUMOR RAD DOSE W BOOST...:
|
|---|
| 173 | 62. NUMBER OF RADIATION TREATMENTS...:
|
|---|
| 174 | 64. DATE CHEMOTHERAPY STARTED........:
|
|---|
| 175 | 65. ADJUVANT CHEMO W BEAM RADIATION..:
|
|---|
| 176 | 66. ADJUVANT THERAPY:
|
|---|
| 177 | CPT 11.............:
|
|---|
| 178 | TAXOL..............:
|
|---|
| 179 | OTHER..............:
|
|---|
| 180 | 67. DURATION OF ADJUVANT THERAPY.....:
|
|---|
| 181 | 68. COMPLETED DURATION OF THERAPY....:
|
|---|
| 182 | 69. WERE OTHER REFERRALS MADE:
|
|---|
| 183 | NUTRITIONAL CONSULTATION.......:
|
|---|
| 184 | OCCUPATIONAL THERAPY...........:
|
|---|
| 185 | PHYSICAL THERAPY...............:
|
|---|
| 186 | OSTOMY CONSULTATION............:
|
|---|
| 187 | 70. DATE OF FIRST RECURRENCE..........:
|
|---|
| 188 | 71. TYPE OF FIRST RECURRENCE..........:
|
|---|
| 189 | 72. DATE OF LAST CONTACT OR DEATH....:
|
|---|
| 190 | 73. VITAL STATUS.....................:
|
|---|
| 191 | 74. CANCER STATUS....................:
|
|---|
| 192 | 75. COMPLETED BY.....................:
|
|---|
| 193 | 76. REVIEWED BY CANCER COMMITTEE.....:
|
|---|
| 194 | Deleting data from the following fields...
|
|---|
| 195 | SURGICAL DX/STAGING PROC
|
|---|
| 196 | SURGICAL DX/STAGING PROC DATE
|
|---|
| 197 | SURGERY OF PRIMARY (R)
|
|---|
| 198 | SURGICAL APPROACH (R)
|
|---|
| 199 | SURGERY OF PRIMARY (F)
|
|---|
| 200 | SURGERY OF PRIMARY DATE
|
|---|
| 201 | SURGICAL MARGINS
|
|---|
| 202 | DATE OF SURGICAL DISCHARGE
|
|---|
| 203 | REASON FOR NO SURGERY
|
|---|
| 204 | SURGERY OF PRIMARY SITE
|
|---|
| 205 | SURGERY OF PRIMARY SITE DATE
|
|---|
| 206 | SCOPE OF LN SURGERY (R)
|
|---|
| 207 | NUMBER OF LN REMOVED (R)
|
|---|
| 208 | SCOPE OF LN SURGERY (F)
|
|---|
| 209 | SCOPE OF LYMPH NODE SURG DATE
|
|---|
| 210 | SURG PROC/OTHER SITE (R)
|
|---|
| 211 | SURG PROC/OTHER SITE (F)
|
|---|
| 212 | SURG PROC/OTHER SITE DATE
|
|---|
| 213 | DATE RADIATION STARTED
|
|---|
| 214 | LOCATION OF RADIATION TX
|
|---|
| 215 | RADIATION TREATMENT VOLUME
|
|---|
| 216 | REGIONAL TREATMENT MODALITY
|
|---|
| 217 | REGIONAL DOSE:cGy
|
|---|
| 218 | BOOST TREATMENT MODALITY
|
|---|
| 219 | BOOST DOSE:cGy
|
|---|
| 220 | NUMBER OF TXS TO THIS VOLUME
|
|---|
| 221 | RADIATION/SURGERY SEQUENCE
|
|---|
| 222 | DATE RADIATION ENDED
|
|---|
| 223 | REASON FOR NO RADIATION
|
|---|
| 224 | TEXT-RX-RADIATION OTHER
|
|---|
| 225 | CHEMOTHERAPY DATE
|
|---|
| 226 | REASON FOR NO CHEMOTHERAPY
|
|---|
| 227 | HORMONE THERAPY
|
|---|
| 228 | HORMONE THERAPY DATE
|
|---|
| 229 | REASON FOR NO HORMONE THERAPY
|
|---|
| 230 | IMMUNOTHERAPY DATE
|
|---|
| 231 | HEMA TRANS/ENDOCRINE PROC
|
|---|
| 232 | HEMA TRANS/ENDOCRINE PROC DATE
|
|---|
| 233 | OTHER TREATMENT
|
|---|
| 234 | OTHER TREATMENT DATE
|
|---|
| 235 | PALLIATIVE PROCEDURE @FAC
|
|---|
| 236 | SURGICAL DX/STAGING @FAC
|
|---|
| 237 | SURGICAL DX/STAGING @FAC DATE
|
|---|
| 238 | SURGERY OF PRIMARY @FAC (R)
|
|---|
| 239 | SURGERY OF PRIMARY @FAC (F)
|
|---|
| 240 | SURGERY OF PRIMARY @FAC DATE
|
|---|
| 241 | SCOPE OF LN SURGERY @FAC (R)
|
|---|
| 242 | NUMBER OF LN REMOVED @FAC (R)
|
|---|
| 243 | SCOPE OF LN SURGERY @FAC (F)
|
|---|
| 244 | SCOPE OF LN SURGERY @FAC DATE
|
|---|
| 245 | SURG PROC/OTHER SITE @FAC (R)
|
|---|
| 246 | SURG PROC/OTHER SITE @FAC (F)
|
|---|
| 247 | SURG PROC/OTHER SITE @FAC DATE
|
|---|
| 248 | RADIATION @FAC DATE
|
|---|
| 249 | CHEMOTHERAPY @FAC DATE
|
|---|
| 250 | HORMONE THERAPY @FAC
|
|---|
| 251 | HORMONE THERAPY @FAC DATE
|
|---|
| 252 | IMMUNOTHERAPY @FAC DATE
|
|---|
| 253 | OTHER TREATMENT @FAC
|
|---|
| 254 | OTHER TREATMENT @FAC DATE
|
|---|
| 255 | STATE AT DX = YY (
|
|---|
| 256 | POSTAL CODE AT DX must be 888888888
|
|---|
| 257 | STATE AT DX = ZZ (
|
|---|
| 258 | POSTAL CODE AT DX must be 999999999
|
|---|
| 259 | REPORTING HOSPITAL = FACILITY REFERRED FROM
|
|---|
| 260 | REPORTING HOSPITAL = FACILITY REFERRED TO
|
|---|
| 261 | CLASS OF CASE =
|
|---|
| 262 | FACILITY REFERRED FROM may not be blank
|
|---|
| 263 | DATE OF FIRST CONTACT..:
|
|---|
| 264 | later than
|
|---|
| 265 | SURGERY OF PRIMARY SITE DATE.:
|
|---|
| 266 | RADIATION DATE...............:
|
|---|
| 267 | RADIATION THERAPY TO CNS DATE:
|
|---|
| 268 | CHEMOTHERAPY DATE............:
|
|---|
| 269 | HORMONE THERAPY DATE.........:
|
|---|
| 270 | IMMUNOTHERAPY DATE...........:
|
|---|
| 271 | OTHER TREATMENT DATE.........:
|
|---|
| 272 | earlier than
|
|---|
| 273 | DATE DX......................:
|
|---|
| 274 | TYPE OF REPORTING SOURCE = 6 (
|
|---|
| 275 | CLASS OF CASE must be 5 (Dx at autopsy)
|
|---|
| 276 | CLASS OF CASE = 5 (
|
|---|
| 277 | TYPE OF REPORTING SOURCE must be 6 (Autopsy only)
|
|---|
| 278 | TYPE OF REPORTING SOURCE = 7 (
|
|---|
| 279 | DIAGNOSTIC CONFIRMATION must be 9 (Unk if microscopically confirmed)
|
|---|
| 280 | DIAGNOSTIC CONFIRMATION must be 1 (Pos histology) or
|
|---|
| 281 | 6 (Direct visualization)
|
|---|
| 282 | is a paired site
|
|---|
| 283 | LATERALITY must be provided for specified paired organs/sites
|
|---|
| 284 | NOTE: If NASAL CARTILAGE or NASAL SEPTUM, override this warning.
|
|---|
| 285 | NOTE: If CARINA, override this warning.
|
|---|
| 286 | NOTE: If STERNUM, override this warning.
|
|---|
| 287 | NOTE: If SACRUM, COCCYX or SYMPHYSIS PUBIS, override this warning.
|
|---|
| 288 | is an unpaired site
|
|---|
| 289 | LATERALITY must be 0 (Not a paired site)
|
|---|
| 290 | BEHAVIOR CODE = 2 (In situ)
|
|---|
| 291 | SUMMARY STAGE =
|
|---|
| 292 | BEHAVIOR CODE and SUMMARY STAGE confict
|
|---|
| 293 | BEHAVIOR CODE = 3 (Malignant)
|
|---|
| 294 | SUMMARY STAGE = 0 (In situ)
|
|---|
| 295 | HISTOLOGY =
|
|---|
| 296 | TYPE OF REPORTING SOURCE =
|
|---|
| 297 | SUMMARY STAGE must be 7 (Distant Mets/systemic disease)
|
|---|
| 298 | GRADE/DIFFERENTIATION must be 1 (Grade I)
|
|---|
| 299 | GRADE/DIFFERENTIATION must be 2 (Grade II)
|
|---|
| 300 | GRADE/DIFFERENTIATION must be 4 (Grade IV)
|
|---|
| 301 | GRADE/DIFFERENTIATION must be: 3 (Grade III)
|
|---|
| 302 | 7 (Null cell)
|
|---|
| 303 | #################### #################### ####################
|
|---|
| 304 | #################### #################### ####################
|
|---|
| 305 | #################### #################### ####################
|
|---|
| 306 | #################### #################### ####################
|
|---|
| 307 | #################### #################### ####################
|
|---|
